Who is boehringer ingelheim

Skip to main content. A successful and family-owned Company Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Boehringer Ingelheim Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. Information for Our Company FuturePack: Innovation in production. Read more on FuturePack: Innovation in production. Our Company Financial Highlights. Read more on Financial Highlights.

Read more on Annual Results Press Conference. Our Company Annual Report Partners. Read more on Annual Report Partners. Our Company Insights into our production. Boehringer Ingelheim makes an important contribution to the reliable supply of pharmaceuticals. Watch the video on Insights into our production.

Watch the video on Company Video: Value through Innovation. Our Company Who we are. Diabetes Atlas 8th edition , International Diabetes Federation. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

We passionately improve health Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. About million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 percent of all cases 1. This number is projected to increase to million people by 1.

Type 2 diabetes is a chronic, progressive condition and long-term complications include stroke, heart attack and cardiovascular death as well as diabetic kidney disease, retinopathy, arm and leg amputations and autonomic neuropathy. Cardiovascular disease.

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide 1. We work together globally and with integrity. Together we shape the future of healthcare.

Read more on how partnerships and long-term cooperation drive our daily work. Innovation in healthcare is about more than just a new approach or technology. We innovate for better health of people and animals. Our growing, highly innovative pipeline focuses on the research and development of healthcare solutions for people with high unmet medical needs. As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.

Antimicrobial resistance is a major global threat to the health of humans and animals alike. Learn about challenges and solutions here. Skip to main content. Information for